Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Unified Voice?
Also keep in mind that if the cost of a license is less than what it would take to purchase PTSC shares we are safe from a buy-out. Right now we could be bought for approximately 200 mil. Until our share price raises dramatically I don't see them pursuing mega-buck infringers.(remember ARM) Additionally, no one would buy us until the USPTO issue is resolved. The more I think about it, I think that TPL/PTSC were the one's who had reservations about this going to trial, and have the court determine validity, we would have lost our advantage of an ex-parta re-exam which is really quite significant. Once we lose that decision the ball game is over, so why fool with our odds. How much they were willing to concede will be determined(for us) in April. The game goes on, and on and on........
Share
New Message
Please login to post a reply